Scaffold hopping of the SYK inhibitor entospletinib leads to broader targeting of the BCR signalosome
Scaffold hopping of the SYK inhibitor entospletinib leads to broader targeting of the BCR signalosome.
European Journal of Medicinal Chemistry.
2020,
204,
112636,
ISSN: 0223-5234,
PMID: 32731189,